Literature DB >> 9754673

Seroprevalence of viral hepatitis in Tanzanian adults.

W C Miller1, J F Shao, D J Weaver, G H Shimokura, D A Paul, G J Lallinger.   

Abstract

In a cross-sectional study in Dar es Salaam, Tanzania, we determined the seroprevalence of markers for hepatitis A, B, C and E viruses and examined associated risk markers. Among 403 healthy adults, the seroprevalence of antibodies to hepatitis A virus was 99.0% (95% confidence interval: 97.5-99.7). Prior exposure to hepatitis C and E viruses was rare (hepatitis C: 0.7% (0.2-2.1); hepatitis E: 0.2% (< 0.1-1.4)). The prevalence of all markers of hepatitis B was 70.7% (66.0-75.1). Hepatitis B surface antigen was identified in 6.0% (3.9-8.7) of subjects. Independent predictors of hepatitis B infection identified by logistic regression included older age, male gender, Muslim religion and type of abode. Given the high prevalence of hepatitis B and the low prevalence of hepatitis C, the majority of chronic viral hepatitis is likely to be associated with hepatitis B. Control efforts should focus primarily on hepatitis B.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9754673     DOI: 10.1046/j.1365-3156.1998.00289.x

Source DB:  PubMed          Journal:  Trop Med Int Health        ISSN: 1360-2276            Impact factor:   2.622


  9 in total

1.  Predictors of Hepatitis B Virus Infection Vaccine Hesitancy Among Pregnant Women Attending Antenatal Care at Lubaga Hospital, Kampala, Uganda.

Authors:  Ismail Bamidele Afolabi; Abdulmujeeb Babatunde Aremu; Lawal Abdurraheem Maidoki; Nnodimele Onuigbo Atulomah
Journal:  Int J Womens Health       Date:  2022-08-17

2.  Global burden of aflatoxin-induced hepatocellular carcinoma: a risk assessment.

Authors:  Yan Liu; Felicia Wu
Journal:  Environ Health Perspect       Date:  2010-02-19       Impact factor: 9.031

3.  Prevalence of hepatitis B virus infection among health care workers in a tertiary hospital in Tanzania.

Authors:  A Mueller; L Stoetter; S Kalluvya; A Stich; C Majinge; B Weissbrich; C Kasang
Journal:  BMC Infect Dis       Date:  2015-09-23       Impact factor: 3.090

4.  Prevalence of hepatitis C virus in mothers and their children in Malawi.

Authors:  James M Fox; Robert Newton; Marija Bedaj; Ada Keding; Elizabeth Molyneux; Lucy M Carpenter; Fabiola Martin; Nora Mutalima
Journal:  Trop Med Int Health       Date:  2015-02-06       Impact factor: 2.622

Review 5.  A systematic review of the epidemiology of hepatitis E virus in Africa.

Authors:  Jong-Hoon Kim; Kenrad E Nelson; Ursula Panzner; Yogita Kasture; Alain B Labrique; Thomas F Wierzba
Journal:  BMC Infect Dis       Date:  2014-06-05       Impact factor: 3.090

Review 6.  Hepatitis B Virus Infection in Tanzania: Current Status and Challenges.

Authors:  Semvua B Kilonzo; Daniel W Gunda; Bonaventura C T Mpondo; Fatma A Bakshi; Hyasinta Jaka
Journal:  J Trop Med       Date:  2018-01-30

7.  The prevalence of human immunodeficiency and of hepatitis B viral infections is not increased in patients with sickle cell disease in Tanzania.

Authors:  Grace Shayo; Irene Makundi; Lucio Luzzatto
Journal:  BMC Infect Dis       Date:  2021-09-30       Impact factor: 3.090

8.  Co-infection of Schistosoma mansoni/hepatitis C virus and their associated factors among adult individuals living in fishing villages, north-western Tanzania.

Authors:  Humphrey D Mazigo; Stella Kepha; Godfrey M Kaatano; Safari M Kinung'hi
Journal:  BMC Infect Dis       Date:  2017-10-10       Impact factor: 3.090

9.  Prevalence of hepatitis B surface antigen (HBsAg) positivity and its associated factors in Rwanda.

Authors:  Jean Damascene Makuza; Jean Olivier Twahirwa Rwema; Corneille Killy Ntihabose; Donatha Dushimiyimana; Justine Umutesi; Marie Paul Nisingizwe; Janvier Serumondo; Muhamed Semakula; David J Riedel; Sabin Nsanzimana
Journal:  BMC Infect Dis       Date:  2019-05-03       Impact factor: 3.090

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.